Computer Tailored Program for Smoking Cessation Among Romanian Adults
NCT ID: NCT02028962
Last Updated: 2014-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
640 participants
INTERVENTIONAL
2013-10-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Program implementation will comprise of :
1. ''diagnosis'' by means of questionnaires at the individual level of characteristics that are relevant for a person's smoking behavior
2. development of the ''message library'' that contains all education messages that may be needed
3. development of an ''algorithm'', a set of decision rules that evaluates the diagnosis, selects and generates messages tailored to the specific needs of the individual user
4. generating of personalized letters for each participant
5. sending of theses personalized letters to the participants. The participants will receive three personalized letters during a period of six months after registration into the program.
The effects of the program will be evaluated with a randomized controlled trial which will assess the changes in smoking behaviour as well as smoking related attitudes, self-efficacy and quiting attempts at 6 months after the enrolment into the program.
A process evaluation will assess participants' opinion about the program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Health Intervention for Family Smoking Cessation in Romania
NCT03689140
Family Smoking Cessation in Romania Using Pregnancy as a Window of Opportunity
NCT02512913
Computer-Based Stop Smoking Program in Assisting Doctors in Helping Adults Stop Smoking
NCT00383461
App for Pregnancy Smoking Cessation With Peer Support
NCT05337722
Computer-Based Program to Facilitate Readiness and Motivation for Smoking Cessation
NCT01326234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lifestyle counseling
The experimental group will receive three letters with advices for smoking cessation-the first letter after the enrolment in the study, the second one one month after the first letter, the third one three months after the first letter
Lifestyle counseling
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle counseling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* smokers who do not intend to quit smoking in the next 6 months
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iuliu Hatieganu University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lucia Maria Lotrean
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lucia M Lotrean, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Iuliu Hatieganu University of Medicine and Pharmacy
Cluj-Napoca, Cluj, Romania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Renuntlafumat
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.